-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q8p3AIsUScpFZsqtiONo5XWiEL6n9oG9rmWRY27jsjR1n+8fYAK1o5GettQ/CkRJ 1u/Dx3trL4ThupW6xrWy4Q== 0000950162-03-001094.txt : 20030806 0000950162-03-001094.hdr.sgml : 20030806 20030806163312 ACCESSION NUMBER: 0000950162-03-001094 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030513 FILED AS OF DATE: 20030806 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOGEN INC CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 128 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6179952506 MAIL ADDRESS: STREET 1: 128 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 03826523 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 BUSINESS PHONE: 1264333455 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHIRE BIOCHEM INC CENTRAL INDEX KEY: 0000867202 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] STATE OF INCORPORATION: E6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 03826524 BUSINESS ADDRESS: STREET 1: 275 ARMAND-FRAPPIER BLVD CITY: LAVAL QUEBEC STATE: E6 ZIP: H7V 4A7 BUSINESS PHONE: 5146811744 MAIL ADDRESS: STREET 1: 275 ARMAND FRAPPIER BLVD CITY: LAVAL QUEBEC STATE: E6 ZIP: H7V 4A7 FORMER NAME: FORMER CONFORMED NAME: BIOCHEM PHARMA INC DATE OF NAME CHANGE: 19930504 FORMER NAME: FORMER CONFORMED NAME: IAF BIOCHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19920310 3 1 shirebioform3080603_ex.xml X0201 3 2003-05-13 0 0000855654 IMMUNOGEN INC IMGN 0000867202 SHIRE BIOCHEM INC 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 H7V 4A7 MONTREAL, CANADA 0 0 1 0 0000936402 SHIRE PHARMACEUTICALS GROUP PLC HAMPSHIRE INTL BUSINESS PARK CHINEHAM BASINGSTOKE HAMPSHIRE ENGLAND RG X0 UNITED KINGDOM 0 0 1 0 Common Stock 4096098 D These shares are owned directly by Shire BioChem Inc., which is a wholly owned subsidiary of Shire Pharmaceuticals Group plc. Shire Pharmaceuticals Group plc is an indirect beneficial owner of the reported securities. Exhibit 99 - Joint Filer Information /s/ Joseph Rus, President & CEO, Shire BioChem Inc. 2003-08-06 EX-99 3 shirebioform3080603ex99.txt JOINT FILER INFORMATION Form 3 Joint Filer Information Name: Shire Pharmaceuticals Group plc Address: Hampshire International Business Park Chineham, Basingstoke Hampshire, England RG24 8EP Designated Filer: Shire BioChem Inc. Issuer & Ticker Symbol: ImmunoGen, Inc. (IMGN) Date of Event Requiring Statement: May 13, 2003 Signature: /s/ Angus Charles Russell ---------------------------------- Name: Angus Charles Russell Title: Group Finance Director -----END PRIVACY-ENHANCED MESSAGE-----